Mar 02, 2020
Resuscitation Devices Market Worth $8.7 Billion by 2025 - Exclusive Report by MarketsandMarkets(TM)
Feb 21, 2020
Study from Ascensia Demonstrates Impact of BGMS Selection on Glycemic Control when Using a Diabetes Management App
Feb 18, 2020
U.S. Department of Defense Awards Funding for Study to Evaluate the Use of INTERCEPT Plasma in Traumatic Burn Resuscitation
Feb 18, 2020
Abbott Introduces Next-Generation Heart Rhythm Management Devices in Europe, Featuring State-of-the-Art Patient App and Bluetooth Connectivity
Feb 11, 2020
Original "Bachelorette" Couple Trista and Ryan Sutter Partner with Starting Hearts to Raise Awareness for Sudden Cardiac Arrest
Feb 06, 2020
Simon's Heart and Nikomed Team Up to Raise Awareness of Screening to Prevent Sudden Cardiac Death in Kids
Jan 30, 2020
Genetesis Pilot study: 90-second scan shows promise in evaluating chest pain patients in Emergency Department observation unit
Jan 29, 2020
Traumatic Brain Injuries in Soldiers Need Immediate Attention & New Solutions
Jan 15, 2020
Health Scholars, the Virtual Reality Healthcare Training Platform, Launches First VR ACLS Training Simulation for First Responders
Jan 13, 2020
Cardisio Demonstrates Unprecedented Accuracy in New Non-Invasive Coronary Artery Disease Detection
Jan 10, 2020
Inflammatix Announces $32 Million in Series C Funding
Dec 18, 2019
NeuroTrauma Sciences Appoints Dr. Todd Verdoorn as Vice President of Research and Development
Dec 18, 2019
ANI Pharmaceuticals Announces Launch of Bretylium Tosylate Injection, USP 50 mg/mL
Dec 13, 2019
Clinical Data from Reprieve Cardiovascular's Successful First-in-Human Therapy for Acute Heart Failure Presented
Dec 12, 2019
Medicure Announces Completion of Enrollment for FABOLUS-FASTER, Phase 4 Clinical Trial of Aggrastat (Tirofiban Hydrochloride) Injection VS Kengreal (Cangrelor) in Patients Undergoing Percutaneous Coronary Intervention (PCI)
Nov 27, 2019
Gunshot Injuries Have Long-term Medical Consequences
Nov 23, 2019
Dosing of first patient in phase 3 pivotal study of sovateltide (PMZ-1620), a first-in-class investigational product, for acute cerebral ischemic stroke
Nov 19, 2019
Faraday Pharmaceuticals Announces Positive Top-Line Results from Phase 2 Trial of FDY-5301 for Treatment of Reperfusion Injury Following a STEMI Heart Attack
Nov 18, 2019
Correvio Announces Presentation of New Brinavess(TM) Spectrum Data at the American Heart Association 2019 Annual Meeting
Nov 18, 2019
Failure to Report Sepsis Symptoms Can Be Deadly Warns Patient Safety Authority